REGULATORY REQUIREMENTS FOR APPROVAL OF OVER THE COUNTER DRUGS AS PER AUSTRAILIAN (TGA) GUIDELINES
Journal Title: Indo American Journal of Pharmaceutical Sciences - Year 2018, Vol 5, Issue 3
Abstract
The Therapeutic Goods Administration is a Commonwealth Government agency that regulates medical devices and drugs. Prescription medicines and over-the-counter medicines which meet Australian standards of quality, safety and efficacy are included on the Australian Register of Therapeutic Goods. Non-prescription or OTC medicines are considered to be ‘low risk’ in comparison with prescription medicines. They are evaluated for quality, safety and efficacy by the TGA and the Medicines Evaluation Committee, in accordance with the Australian Regulatory Guidelines for OTC Medicines, 1 July 2003 before they may be registered on the ARTG. TGA is monitoring the all aspects for drug approvals and monitoring the human health. As per the TGA act all the medicines are classified in to prescription, non-prescription medicines and export only medicines. TGA act states those medicines require registering or listing at TGA. Registration and listing requirements are based on the level of risk. All prescription and some non-prescription medicines are required to register at TGA and some non-prescription medicines and export only medicines are need to list at TGA. TGA has adopted the most of the EDQM guidelines for medicines. Post marketing activities of the TGA include investigating reports of problems, laboratory testing of products on the market, and monitoring to ensure compliance with the legislation. Keywords: TGA, ARTG, OTC, Non-prescription.
CHEMICAL CONSTITUENTS AND PHARMACOLOGICAL EFFECTS OF HYPERICUM TRIQUETRIFOLIUM
Hypericum triquetrifolium contained many biologically active chemicals included acylphloroglucinols triquetrireboudin, triquetriborin, essential and volatile oils and many phenolic compounds. Hypericum triquetrifolium co...
DEVELOPMENT AND EVALUATION OF CONTROLLED RELEASE MICROSPHERES CONTAINING ROPINIROLE HCL
Current investigation explains the preparation of alginate microspheres of Ropinirole by ionotropic gelation technique, we sought to develop novel Ropinirole microspheres and explore the influence of various concentratio...
METHOD DEVELOPMENT AND VALIDATION OF DACLATASVIR IN BULK & PHARMACEUTICAL DOSAGE FORM BY UV-VISIBLE SPECTROPHOTOMETRY
Objective: The objective of the present work is to develop a simple, efficient, and reproducible spectrophotometric method for the quantitative estimation of hepatitis-C drug - Daclatasvir in active pharmaceutical ingred...
GREEN SYNTHESIS OF N’-SUBSTITUTED-N”-[4-HYDROXY-3- (1H-INDOL-2-YL) PHENYLDICARBONODITHIOIMIDEDIAMIDE
In this work we synthesized a novel series of N’-substituted-N”-[4-hydroxy-3-(1H-indol-2-yl) phenyldicarbonodithioimidediamide by green synthesis parameters from N’-[4-hydroxy-3-(1H-indol-2-yl) phenyl] thiourea and subst...
METHOD DEVELOPMENT, VALIDATION AND STABILITY INDICATING ASSAY PROCEDURE OF PREGABALIN BY USING RP-HPLC
A simple, rapid and precise Reverse phase liquid chromatographic method has been developed and subsequently validated for estimation of Pregabalin in tablet dosage form. The method is based on High Performance Liquid Chr...